Current stock page

Financial Data

INCY Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareBiotechnologyScore data as of Sep 1, 2026

INCY

Financial Data
Incyte Corporation
Healthcare· Biotechnology
AIQ Score
BullishAIQ Edge 10/10
Leader
Sector Leader
Score data as of Sep 1, 2026
Last price
$125.01
+$1.79 (+1.45%)
Latest market quote
Momentum68
Value54
Quality90
Risk Resilience75
Sentiment
View financial data

Financial Data Overview

Detailed revenue, earnings, margins, balance sheet, cash flow, valuation metrics, technical indicators, and risk measures for deeper research.

Quarterly periods
8
Fundamental metrics
10
Technical indicators
12
Risk measures
6

Quarterly Financial Statements

Updated Sep 2, 2026.

Income statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Revenue$1.67B$1.27B$1.51B$1.37B$1.22B$1.05B$1.18B$1.14B
Gross Profit$1.57B$1.17B$1.37B$1.27B$1.12B$963.35M$1.07B$1.04B
Operating Income
Net Income$585.61M$303.33M$299.28M$424.17M$405M$158.2M$201.21M$106.46M
EPS$2.92$1.52$1.52$2.17$2.09$0.82$1.04$0.55
Cash flow statement
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Operating Cash Flow$507.66M$369.35M$543.3M$559.39M$44.74M$266.07M$381.22M$310.87M
Capital Expenditure-$12.41M-$10.2M-$21.88M-$14.75M-$19.07M-$3.17M-$17.38M-$17.69M
Free Cash Flow$495.25M$359.15M$521.42M$544.64M$25.67M$262.9M$363.83M$293.18M
Net Cash Provided By Operating Activities$507.66M$369.35M$543.3M$559.39M$44.74M$266.07M$381.22M$310.87M
Balance sheet
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Assets$7.87B$7.34B$6.96B$6.33B$5.82B$5.75B$5.44B$5.01B
Total Debt$38.27M$33.83M$69.25M$41.27M$42.41M$43.12M$43.54M$36.51M
Cash And Cash Equivalents
Total Liabilities$1.53B$1.79B$1.8B$1.68B$1.65B$2.08B$2B$1.84B
Total Stockholders Equity$6.34B$5.55B$5.15B$4.65B$4.17B$3.67B$3.45B$3.17B
Key financial metrics
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio9.7115.4816.299.788.1518.5416.5829.9
P/B ratio3.583.383.773.573.173.23.874.02
P/S ratio13.5714.7412.9412.1510.8711.1411.3211.19
Debt To Equity0.010.010.010.010.010.010.010.01
Free Cash Flow Yield
Financial ratios
8 periods
Metric2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
P/E ratio
P/B ratio3.583.383.773.573.173.23.874.02
P/S ratio13.5714.7412.9412.1510.8711.1411.3211.19
Return On Equity9.23%5.46%5.79%9.12%9.71%4.31%5.84%3.36%
Debt To Equity

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
Pe
14.89
multipleSep 1, 2026
Pb
3.82
multipleSep 1, 2026
Revenue Growth Yoy
31.54
percentSep 1, 2026
EPS Growth Yoy
92.11
percentSep 1, 2026
Gross Margin
92.62
percentSep 1, 2026
Operating Margin
31.57
percentSep 1, 2026
ROE
29.7
percentSep 1, 2026
ROIC
24.59
percentSep 1, 2026
Debt To Equity
0.01
ratioSep 1, 2026
FCF Yield
7.83
percentSep 1, 2026
Technical indicators
Close
125.01
priceSep 1, 2026
Volume
1,191,993
volumeSep 1, 2026
Rsi14
60.09
indexSep 1, 2026
MACD
2.11
indexSep 1, 2026
MACD Signal
2.59
indexSep 1, 2026
MACD Histogram
-0.48
indexSep 1, 2026
Adx14
20.74
indexSep 1, 2026
Sma50
119.54
priceSep 1, 2026
Sma200
104.37
priceSep 1, 2026
Atr14
3.38
priceSep 1, 2026
Historical Volatility
0.24
percentSep 1, 2026
Volume Ma20
1,278,914.95
volumeSep 1, 2026
Risk measures
Resilience Score
75
score_0_100Sep 1, 2026
Beta
0.77
ratioSep 1, 2026
Volatility Annual
33.02
percentSep 1, 2026
Max Drawdown
-18.33
percentSep 1, 2026
Sharpe Ratio
1.23
ratioSep 1, 2026
Var95
-2.75
percentSep 1, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

INCY Financial Data FAQ

What is Incyte Corporation's revenue?

Incyte Corporation's revenue is one of the core financial data points for INCY. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Incyte Corporation's revenue growing?

Revenue growth shows whether Incyte Corporation is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is INCY's EPS?

INCY's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Incyte Corporation's net income?

Incyte Corporation's net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Incyte Corporation generate?

Free cash flow shows how much cash Incyte Corporation generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Incyte Corporation have?

Cash and debt help frame INCY's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.